Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission

NCT01603251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artemether-lumefantrine combination
DRUG: Artemether-lumefantrine combination + single dose Ivermectin
DRUG: Artemether-lumefantrine combination + repeated dose Ivermectin

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]
[object Object]